Korro Bio, Inc. Other Comprehensive Income (Loss), Net of Tax
Korro Bio, Inc. (KRRO) reported Other Comprehensive Income (Loss), Net of Tax of -$194.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- Korro Bio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$194.00K.
- Korro Bio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$207.00K.
- Korro Bio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $37.00K, a 93.31% decline year-over-year.
- Korro Bio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$87.00K, a 514.29% decline year-over-year.
- Korro Bio, Inc. other comprehensive income (loss), net of tax for fiscal 2025 was -$56.00K, a 120.90% decline from fiscal 2024.
- Korro Bio, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $268.00K, a 5260.00% increase from fiscal 2023.
- Korro Bio, Inc. other comprehensive income (loss), net of tax for fiscal 2023 was $5.00K, a 150.00% increase from fiscal 2022.
- Korro Bio, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was $2.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$194.00K 10-Q · filed 2026-08-06 | -$401.00K derived: sum of 2 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$207.00K 10-Q · filed 2026-08-06 | |||||
| 2025-12-31 | -$56.00K 10-K · filed 2026-03-12 | |||||
| 2025-09-30 | $37.00K 10-Q · filed 2025-11-12 | -$50.00K derived: sum of 2 quarters · filed 2026-08-06 | -$54.00K derived: sum of 3 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$87.00K 10-Q · filed 2026-08-06 | -$91.00K derived: sum of 2 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$4.00K 10-Q · filed 2026-08-06 | |||||
| 2024-12-31 | $268.00K 10-K · filed 2026-03-12 | |||||
| 2024-09-30 | $553.00K 10-Q · filed 2024-11-12 | $574.00K derived: sum of 2 quarters · filed 2024-11-12 | ||||
| 2024-06-30 | $21.00K 10-Q · filed 2024-11-12 | |||||
| 2023-12-31 | -$203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$187.00K derived: sum of 2 quarters · filed 2025-03-18 | -$129.00K derived: sum of 3 quarters · filed 2025-03-18 | $5.00K 10-K · filed 2025-03-18 | ||
| 2023-09-30 | $16.00K 10-Q · filed 2023-11-02 | $74.00K derived: sum of 2 quarters · filed 2023-11-02 | $208.00K 10-Q · filed 2023-11-02 | $395.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $58.00K 10-Q · filed 2023-08-10 | $192.00K 10-Q · filed 2023-08-10 | $379.00K derived: sum of 3 quarters · filed 2024-11-12 | $395.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $5.00K 10-Q · filed 2024-11-12 | $134.00K 10-Q · filed 2023-05-12 | $321.00K derived: sum of 2 quarters · filed 2024-11-12 | $337.00K derived: sum of 3 quarters · filed 2024-11-12 | $241.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2022-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $332.00K derived: sum of 2 quarters · filed 2024-03-26 | $236.00K derived: sum of 3 quarters · filed 2024-03-26 | $2.00K 10-K · filed 2024-03-26 | -$136.00K 10-K · filed 2023-03-10 | |
| 2022-09-30 | $16.00K 10-Q · filed 2023-11-02 | -$80.00K derived: sum of 2 quarters · filed 2023-11-02 | -$314.00K 10-Q · filed 2023-11-02 | -$379.00K derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | -$96.00K 10-Q · filed 2023-08-10 | -$330.00K 10-Q · filed 2023-08-10 | -$395.00K derived: sum of 3 quarters · filed 2023-08-10 | -$399.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | -$234.00K 10-Q · filed 2023-05-12 | -$299.00K derived: sum of 2 quarters · filed 2023-05-12 | -$303.00K derived: sum of 3 quarters · filed 2023-05-12 | -$306.00K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | -$69.00K derived: sum of 2 quarters · filed 2023-03-10 | -$72.00K derived: sum of 3 quarters · filed 2023-03-10 | -$89.00K 10-K · filed 2023-03-10 | ||
| 2021-09-30 | -$4.00K 10-Q · filed 2022-11-08 | -$7.00K derived: sum of 2 quarters · filed 2022-11-08 | -$24.00K 10-Q · filed 2022-11-08 | -$41.00K derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | -$3.00K 10-Q · filed 2022-08-09 | -$20.00K 10-Q · filed 2022-08-09 | -$37.00K derived: sum of 3 quarters · filed 2022-08-09 | -$53.00K derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | -$17.00K 10-Q · filed 2022-05-04 | -$34.00K derived: sum of 2 quarters · filed 2022-05-04 | -$50.00K derived: sum of 3 quarters · filed 2022-05-04 | $25.00K derived: sum of 4 quarters · filed 2022-05-04 | ||
| 2020-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$33.00K derived: sum of 2 quarters · filed 2022-03-15 | $42.00K derived: sum of 3 quarters · filed 2022-03-15 | -$27.00K 10-K · filed 2022-03-15 | ||
| 2020-09-30 | -$16.00K 10-Q · filed 2021-11-15 | $59.00K derived: sum of 2 quarters · filed 2021-11-15 | -$10.00K 10-Q · filed 2021-11-15 | -$72.00K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $75.00K 10-Q · filed 2021-08-12 | $6.00K 10-Q · filed 2021-08-12 | -$56.00K derived: sum of 3 quarters · filed 2021-08-12 | -$90.00K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$69.00K 10-Q · filed 2021-05-13 | -$131.00K derived: sum of 2 quarters · filed 2021-05-13 | -$165.00K derived: sum of 3 quarters · filed 2021-05-13 | -$85.00K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$96.00K derived: sum of 2 quarters · filed 2021-03-29 | -$16.00K derived: sum of 3 quarters · filed 2021-03-29 | $54.00K 10-K · filed 2021-03-29 | ||
| 2019-09-30 | -$34.00K 10-Q · filed 2020-11-16 | $46.00K derived: sum of 2 quarters · filed 2020-11-16 | $116.00K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $80.00K 10-Q · filed 2020-08-12 | $150.00K 10-Q · filed 2020-08-12 | ||||
| 2019-03-31 | $70.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |